Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

sanofi-aventis
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 17/07/2007
SPC Merbentyl Syrup

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/07/2007 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   12/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 7 - change marketing authorisation holder to sanofi-aventis
Updated on 09/08/2005 and displayed until 17/07/2007
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 25/02/2003 and displayed until 09/08/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/01/0001 and displayed until 25/02/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 01/01/0001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  dicycloverine